# Safety and Efficacy of a Sub-epitheilal Transform™ Corneal Allograft (TCA) for Presbyopia Correction

> **NCT03675438** · NA · WITHDRAWN · sponsor: **Allotex, Inc.**

## Conditions studied

- Presbyopia
- Refractive Errors

## Interventions

- **OTHER:** Sub-epitheilal TCA Inlay

## Key facts

- **NCT ID:** NCT03675438
- **Lead sponsor:** Allotex, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2018-10
- **Primary completion:** 2021-01
- **Final completion:** 2021-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** The sponsor determined that one study (PRO-010) was sufficient
- **Last updated:** 2020-03-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03675438

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03675438, "Safety and Efficacy of a Sub-epitheilal Transform™ Corneal Allograft (TCA) for Presbyopia Correction". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03675438. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*